$6.53 -0.3 -4.3%
Last Trade - 03/03/21
| Market Cap | ÂŁ3.40bn |
| Enterprise Value | ÂŁ3.40bn |
| Revenue | ÂŁn/a |
| Position in Universe | 1428th / 6643 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 920.4 | 1,103 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
MultiPlan Corporation, formerly Churchill Capital Corp III, is a provider of data analytics and technology-enabled end-to-end cost management solutions to the healthcare industry. The Company's services include medical payment integrity, dental payment integrity, network-based services and analytics-based services. Leveraging technology and data analytics, the Company interprets clients’ needs and customizes solutions. Its medical payment integrity service combines automation with clinical review. The Company's dental payment integrity services offer an automated, pre-payment detection system that targets all claims. Its intelligent algorithms mimic the outcome of a review by a dentist trained in informatics and forensics. It contracts with healthcare providers to offer network-based services. The Company's analytics-based services takes cues from the data to customize solutions for out-of-network healthcare cost management.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Financials |
| Industry | Holding Companies |
| Index | |
| Exchange | New York Stock Exchange |
| Shares in Issue | 694,961,272 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 115 Fifth Avenue, NEW YORK, 10003, United States |
| Web | https://iii.churchillcapitalcorp.com/ |
| Phone | +1 212 3807500 |
| Contact | () |
| Auditors | Marcum LLP |
As of 03/03/21, shares in Multiplan are trading at $6.53, giving the company a market capitalisation of ÂŁ3.40bn. This share price information is delayed by 15 minutes.
Shares in Multiplan are currently trading at $6.53 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Multiplan price has moved by % over the past year.
There are no analysts currently covering Multiplan.
Multiplan is scheduled to issue upcoming financial results on the following dates:
Multiplan does not currently pay a dividend.
Multiplan does not currently pay a dividend.
Multiplan does not currently pay a dividend.
To buy shares in Multiplan you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Multiplan are currently trading at $6.53, giving the company a market capitalisation of ÂŁ3.40bn.
Here are the trading details for Multiplan:
Based on an overall assessment of its quality, value and momentum, Multiplan is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Multiplan are currently priced at $6.53. At that level they are trading at 0.12% discount to the analyst consensus target price of 0.00.
Analysts covering Multiplan currently have a consensus Earnings Per Share (EPS) forecast of -0.14 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Multiplan. Over the past six months, the relative strength of its shares against the market has been -45.94%. At the current price of $6.53, shares in Multiplan are trading at -27.09% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Multiplan.
We were unable to find the directors for Multiplan.
Here are the top five shareholders of Multiplan based on the size of their shareholding:
